Clinical Trial Update: Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 comparative bioavailability study evaluating a 10 mg aripiprazole oral soluble film against the 10 mg Abilify tablet in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)
• Aripiprazole oral soluble film (aripiprazole)

Snippet

Sponsor: CMG Pharmaceutical Co. Ltd | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED